Original Article | Published:

Disruption of cytochrome c oxidase function induces the Warburg effect and metabolic reprogramming

Oncogene volume 35, pages 15851595 (24 March 2016) | Download Citation

Abstract

Defects in mitochondrial oxidative phosphorylation complexes, altered bioenergetics and metabolic shift are often seen in cancers. Here we show a role for the dysfunction of the electron transport chain component cytochrome c oxidase (CcO) in cancer progression. We show that genetic silencing of the CcO complex by shRNA expression and loss of CcO activity in multiple cell types from the mouse and human sources resulted in metabolic shift to glycolysis, loss of anchorage-dependent growth and acquired invasive phenotypes. Disruption of the CcO complex caused loss of transmembrane potential and induction of Ca2+/Calcineurin-mediated retrograde signaling. Propagation of this signaling includes activation of PI3-kinase, IGF1R and Akt, Ca2+-sensitive transcription factors and also TGFβ1, MMP16 and periostin, which are involved in oncogenic progression. Whole-genome expression analysis showed the upregulation of genes involved in cell signaling, extracellular matrix interactions, cell morphogenesis, cell motility and migration. The transcription profiles reveal extensive similarity to retrograde signaling initiated by partial mitochondrial DNA depletion, although distinct differences are observed in signaling induced by CcO dysfunction. The possible CcO dysfunction as a biomarker for cancer progression was supported by data showing that esophageal tumors from human patients show reduced CcO subunits IVi1 and Vb in regions that were previously shown to be the hypoxic core of the tumors. Our results show that mitochondrial electron transport chain defect initiates a retrograde signaling. These results suggest that a defect in the CcO complex can potentially induce tumor progression.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Accessions

Gene Expression Omnibus

References

  1. 1.

    . On respiratory impairment in cancer cells. Science 1956; 124: 269–270.

  2. 2.

    , , . Mitochondrial mutations in cancer. Oncogene 2006; 25: 4647–4662.

  3. 3.

    , , . Mitochondrial mutations mutations in human cancer. Oncogene 2006; 25: 4663–4674.

  4. 4.

    , , , , . Altered metabolism and mitochondrial genome in prostate cancer. J Clin Pathol 2006; 59: 10–16.

  5. 5.

    , , , . Mitochondrial cytochrome B gene mutation promotes tumor growth in bladder cancer. Cancer Res 2008; 68: 700–706.

  6. 6.

    , , , , , et al. m.6267G>A: a recurrent mutation in the human mitochondrial DNA that reduces cytochrome c oxidase activity and is associated with tumors. Hum Mutat 2006; 27: 575–582.

  7. 7.

    , , , , , et al. Cancer type-specific modulation of mitochondrial haplogroups in breast, colorectal and thyroid cancer. BMC Cancer 2010; 10: 421.

  8. 8.

    , , , , , . Mitochondrial stress-induced calcium signaling, phenotypic changes and invasive behavior in human lung carcinoma A549 cells. Oncogene 2002; 21: 7839–7849.

  9. 9.

    , , , , , et al. Retrograde Ca2+ signaling in C2C12 skeletal myocytes in response to mitochondrial genetic and metabolic stress: a novel mode of inter-organelle crosstalk. EMBO J 1999; 18: 522–533.

  10. 10.

    , , , . Heterogeneous nuclear ribonucleoprotein A2 is a common transcriptional coactivator in the nuclear transcription response to mitochondrial respiratory stress. Mol Biol Cell 2009; 20: 4107–4119.

  11. 11.

    , , , , . Activation of Akt is essential for the propagation of mitochondrial respiratory stress signaling and activation of the transcriptional coactivator heterogeneous ribonucleoprotein A2. Mol Biol Cell 2010; 21: 3578–3589.

  12. 12.

    , , , , , . A distinctive physiological role for IkappaBbeta in the propagation of mitochondrial respiratory stress signaling. J Biol Chem 2008; 283: 12586–12594.

  13. 13.

    , , , , , et al. Mitochondrial retrograde signaling induces epithelial-mesenchymal transition and generates breast cancer stem cells. Oncogene 2013; 33: 5238–5250.

  14. 14.

    , , , , , et al. Role of nuclear-encoded subunit Vb in the assembly and stability of cytochrome c oxidase complex: implications in mitochondrial dysfunction and ROS production. Biochem J 2009; 420: 439–449.

  15. 15.

    , , , . Cytochrome c oxidase subunit IV is essential for assembly and respiratory function of the enzyme complex. J Bioenerg Biomembr 2006; 38: 283–291.

  16. 16.

    , , , , , et al. Additive effects of mitochondrion-targeted cytochrome CYP2E1 and alcohol toxicity on cytochrome c oxidase function and stability of respirosome complexes. J Biol Chem 2012; 287: 15284–15297.

  17. 17.

    , , , , , . Protein kinase A-mediated phosphorylation modulates cytochrome c oxidase function and augments hypoxia and myocardial ischemia-related injury. J Biol Chem 2006; 281: 2061–2070.

  18. 18.

    , , , , , . Site specific phosphorylation of cytochrome c oxidase subunits I, IVi1 and Vb in rabbit hearts subjected to ischemia/reperfusion. FEBS Lett 2007; 581: 1302–1310.

  19. 19.

    , , , , . Calcineurin transgenic mice have mitochondrial dysfunction and elevated superoxide production. Am J Physiol Cell Physiol 2003; 284: C562–C570.

  20. 20.

    , , , , , . HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells. Cell 2007; 129: 111–122.

  21. 21.

    , , , , , . Architecture of active mammalian respiratory chain supercomplexes. J Biol Chem 2006; 281: 15370–15375.

  22. 22.

    , . Supramolecular organization of protein complexes in the mitochondrial inner membrane. Biochim Biophys Acta 2009; 1793: 117–124.

  23. 23.

    , , , , . Respiratory active mitochondrial supercomplexes. Mol Cell 2008; 32: 529–539.

  24. 24.

    , . Altered fusion dynamics underlie unique morphological changes in mitochondria during hypoxia-reoxygenation stress. Cell Death Differ 2011; 18: 1561–1572.

  25. 25.

    , , , . Mitochondria to nucleus stress signaling: a distinctive mechanism of NFkappaB/Rel activation through calcineurin-mediated inactivation of IkappaBbeta. J Cell Biol 2003; 161: 507–519.

  26. 26.

    , , . Mitochondria-to-nucleus stress signaling in mammalian cells: nature of nuclear gene targets, transcription regulation, and induced resistance to apoptosis. Gene 2005; 354: 132–139.

  27. 27.

    , . Mitochondrial signaling: the retrograde response. Mol Cell. 2004; 14: 1–15.

  28. 28.

    , , , . Activation of a novel calcineurin-mediated insulin-like growth factor-1 receptor pathway, altered metabolism, and tumor cell invasion in cells subjected to mitochondrial respiratory stress. J Biol Chem 2007; 282: 14536–14546.

  29. 29.

    , . Targeting hypoxia in cancer therapy. Nat Rev Cancer 2011; 11: 393–410.

  30. 30.

    , , , , , et al. Hypoxia induces IGFBP3 in esophageal squamous cancer cells through HIF-1alpha-mediated mRNA transcription and continuous protein synthesis. FASEB J 2012; 26: 2620–2630.

  31. 31.

    , . Oxygen sensing by mitochondria at complex III: the paradox of increased reactive oxygen species during hypoxia. Exp Physiol 2006; 91: 807–819.

  32. 32.

    , , , . Functional and morphological impact of ER stress on mitochondria. J Cell Physiol 2013; 228: 1802–1818.

  33. 33.

    , , . Stress-responsive regulation of mitochondria through the ER unfolded protein response. Trends Endocrinol Metab 2014; 25: 528–537.

  34. 34.

    . Mitochondria and cancer. Nat Rev Cancer 2012; 12: 685–698.

  35. 35.

    . The role of mitochondria in the oncogenic signal transduction. Int J Biochem Cell Biol 2014; 48: 11–17.

  36. 36.

    , , , , , . Mitochondrial DNA depletion in prostate epithelial cells promotes anoikis resistance and invasion through activation of PI3K/Akt2. Cell Death Differ 2009; 16: 571–583.

  37. 37.

    . Mitochondrial DNA mutations in diseases of energy metabolism. J Bioenerg Biomembr 1994; 26: 241–250.

  38. 38.

    , , , , , et al. Mitochondrial respiration defects in cancer cells cause activation of Akt survival pathway through a redox-mediated mechanism. J Cell Biol 2006; 175: 913–923.

  39. 39.

    , , , , , . Mitochondria-to-nucleus stress signaling induces phenotypic changes, tumor progression and cell invasion. EMBO J 2001; 20: 1910–1920.

  40. 40.

    , . Mitochondrial retrograde signaling at the crossroads of tumor bioenergetics, genetics and epigenetics. Mitochondrion 2013; 13: 577–591.

  41. 41.

    , , , , , et al. ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science 2008; 320: 661–664.

  42. 42.

    , , , , , . Mitochondrial respiratory complex I dysfunction promotes tumorigenesis through ROS alteration and AKT activation. Hum Mol Genet 2011; 20: 4605–4616.

  43. 43.

    , , . SDH mutations in cancer. Biochim Biophys Acta 2011; 1807: 1432–1443.

  44. 44.

    , , , , , . Screen for IDH1, IDH2, IDH3, D2HGDH and L2HGDH mutations in glioblastoma. PLoS One 2011; 6: e19868.

  45. 45.

    , , , , , et al. Structural basis of fumarate hydratase deficiency. J Inherit Metab Dis 2011; 34: 671–676.

  46. 46.

    , . Cytochrome c oxidase dysfunction in oxidative stress. Free Radic Biol Med 2012; 53: 1252–1263.

  47. 47.

    , , , . Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J Biol Chem 1994; 269: 23757–23763.

  48. 48.

    , , , , , et al. Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: a mechanism of O2 sensing. J Biol Chem 2000; 275: 25130–25138.

  49. 49.

    , . Involvement of cytochrome c oxidase subunits Va and Vb in the regulation of cancer cell metabolism by Bcl-2. Cell Death Differ 2010; 17: 408–420.

  50. 50.

    , , , , , . Human cyclin D1 oncogene and esophageal squamous cell carcinoma. Cancer 1995; 76: 541–549.

  51. 51.

    , , , , . Molecular and cellular features of esophageal cancer cells. J Cancer Res Clin Oncol 1993; 119: 441–449.

  52. 52.

    , , , , , . Oxidative stress induced mitochondrial protein kinase A mediates cytochrome c oxidase dysfunction. PLoS One 2013; 8: e77129.

  53. 53.

    , , , . Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265–275.

  54. 54.

    , , , , . Assembly of cytochrome-c oxidase in cultured human cells. Eur J Biochem 1998; 254: 389–394.

  55. 55.

    , , , , , . Intracellular pH governs the subcellular distribution of hexokinase in a glioma cell line. Biochem J 1996; 313: 957–962.

  56. 56.

    , , , , . Allosteric activation of pyruvate kinase via NAD+ in rat liver cells. Eur J Biochem 2001; 268: 3943–3949.

  57. 57.

    , . Differential effects of constitutively active phosphatidylinositol 3-kinase on glucose transport, glycogen synthase activity, and DNA synthesis in 3T3-L1 adipocytes. Mol Cell Biol 1997; 17: 190–198.

  58. 58.

    , , , , , et al. Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cells. Cell 2009; 137: 821–834.

  59. 59.

    . 8-21-2014Ref Type: Online Source.

  60. 60.

    , , . Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009; 4: 44–57.

Download references

Acknowledgements

This work was supported by NIH grants CA-22762 and GM-34883, and an endowment from the Harriet Ellison Woodward Trust to NGA and a grant to SS from Mitochondria research affinity group, Children’s hospital of Philadelphia. We also acknowledge the help of the Imaging Core facility at the School of Veterinary Medicine and the NIH/NIDDK Center for Molecular Studies in Digestive and Liver Diseases (P30DK050306) and its Molecular Pathology and Imaging Core facilities at the Perelman School of Medicine.

Author information

Affiliations

  1. Department of Biomedical Sciences, The Mari Lowe Center for Comparative Oncology, School of Veterinary Medicine, Philadelphia, PA, USA

    • S Srinivasan
    • , M Guha
    • , D W Dong
    • , G Ruthel
    •  & N G Avadhani
  2. Division of Gastroenterology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA

    • K A Whelan
    •  & H Nakagawa
  3. Department of Digestive Surgery, Breast and Thyroid Surgery, Graduate School of Medicine, Kagoshima University, Kagoshima, Japan

    • Y Uchikado
    •  & S Natsugoe

Authors

  1. Search for S Srinivasan in:

  2. Search for M Guha in:

  3. Search for D W Dong in:

  4. Search for K A Whelan in:

  5. Search for G Ruthel in:

  6. Search for Y Uchikado in:

  7. Search for S Natsugoe in:

  8. Search for H Nakagawa in:

  9. Search for N G Avadhani in:

Competing interests

The authors declare no conflict of interest.

Corresponding author

Correspondence to N G Avadhani.

Supplementary information

About this article

Publication history

Received

Revised

Accepted

Published

DOI

https://doi.org/10.1038/onc.2015.227

Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)

Further reading